Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Tuberculosis mortality: patient characteristics and causes

Authors: Chou-Han Lin, Chou-Jui Lin, Yao-Wen Kuo, Jann-Yuan Wang, Chia-Lin Hsu, Jong-Min Chen, Wern-Cherng Cheng, Li-Na Lee

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

In the antibiotic era, tuberculosis (TB) still causes a substantial number of mortalities. We aimed to identify the causes and risks of death among TB patients.

Methods

Medical records of mortality cases of culture-proven TB diagnosed during 2003–2007 were reviewed. All TB deaths were classified into 2 groups (TB-related and non-TB-related), based on the underlying cause of death.

Results

During the study period, 2016 cases (male: 71.1%) of culture-proven TB were identified. The mean age was 59.3 (range: 0.3–96) years. The overall mortality rate was 12.3% (249 cases) and the mean age at death was 74 years; 17.3% (43 cases) of all TB deaths were TB-related. Most of the TB-related deaths occurred early (median survival: 20 days), and the patient died of septic shock. Malignancy, liver cirrhosis, renal failure, and miliary and pneumonic radiographic patterns were all independent predictors for all TB deaths. Cavitary, miliary and pneumonic radiographic patterns were all significant predictive factors for TB-related death. Extrapulmonary involvement and liver cirrhosis were also factors contributing to TB-related death.

Conclusions

The majority of TB deaths were ascribed to non-TB-related causes. Managing TB as well as underlying comorbidities in a multidisciplinary approach is essential to improve the outcome of patients in an aging population. However, the clinical manifestations of patients with TB-related death vary; many progressed to fulminant septic shock requiring timely recognition with prompt treatment to prevent early death.
Appendix
Available only for authorised users
Literature
1.
go back to reference Smith A, Miller RF, Story A, Booth HL: A&E department: a missed opportunity for diagnosis of TB?. Thorax. 2006, 61 (4): 364-365. 10.1136/thx.2005.053637.CrossRefPubMedPubMedCentral Smith A, Miller RF, Story A, Booth HL: A&E department: a missed opportunity for diagnosis of TB?. Thorax. 2006, 61 (4): 364-365. 10.1136/thx.2005.053637.CrossRefPubMedPubMedCentral
2.
go back to reference World Health Organization: Global tuberculosis control: WHO report 2013. 2013, Geneva, Switzerland: World Health Organization World Health Organization: Global tuberculosis control: WHO report 2013. 2013, Geneva, Switzerland: World Health Organization
3.
go back to reference Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE: Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis. 2002, 34 (6): 752-759. 10.1086/338784.CrossRefPubMed Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE: Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis. 2002, 34 (6): 752-759. 10.1086/338784.CrossRefPubMed
4.
go back to reference Waitt CJ, Squire SB: A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011, 15 (7): 871-885. 10.5588/ijtld.10.0352.CrossRefPubMed Waitt CJ, Squire SB: A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011, 15 (7): 871-885. 10.5588/ijtld.10.0352.CrossRefPubMed
5.
go back to reference World Health Organization: Global Tuberculosis Programme. A framework for effective tuberculosis control. WHO/TB/94.179. 1994, Geneva, Switzerland: WHO World Health Organization: Global Tuberculosis Programme. A framework for effective tuberculosis control. WHO/TB/94.179. 1994, Geneva, Switzerland: WHO
6.
go back to reference Rao VK, Iademarco EP, Fraser VJ, Kollef MH: The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998, 114 (5): 1244-1252. 10.1378/chest.114.5.1244.CrossRefPubMed Rao VK, Iademarco EP, Fraser VJ, Kollef MH: The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998, 114 (5): 1244-1252. 10.1378/chest.114.5.1244.CrossRefPubMed
7.
go back to reference Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N: Mortality among tuberculosis patients in The Netherlands in the period 1993–1995. Eur Respir J. 1998, 11 (4): 816-820. 10.1183/09031936.98.11040816.CrossRefPubMed Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N: Mortality among tuberculosis patients in The Netherlands in the period 1993–1995. Eur Respir J. 1998, 11 (4): 816-820. 10.1183/09031936.98.11040816.CrossRefPubMed
8.
go back to reference Hansel NN, Merriman B, Haponik EF, Diette GB: Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality. Chest. 2004, 126 (4): 1079-1086. 10.1378/chest.126.4.1079.CrossRefPubMed Hansel NN, Merriman B, Haponik EF, Diette GB: Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality. Chest. 2004, 126 (4): 1079-1086. 10.1378/chest.126.4.1079.CrossRefPubMed
10.
go back to reference Moorman J, Edginton ME: Cause of death of patients on treatment for tuberculosis: a study in a rural South African hospital. Int J Tuberc Lung Dis. 1999, 3 (9): 786-790.PubMed Moorman J, Edginton ME: Cause of death of patients on treatment for tuberculosis: a study in a rural South African hospital. Int J Tuberc Lung Dis. 1999, 3 (9): 786-790.PubMed
11.
go back to reference Shen X, Deriemer K, Yuan Z, Shen M, Xia Z, Gui X, Wang L, Mei J: Deaths among tuberculosis cases in Shanghai, China: who is at risk?. BMC Infect Dis. 2009, 17 (9): 95-CrossRef Shen X, Deriemer K, Yuan Z, Shen M, Xia Z, Gui X, Wang L, Mei J: Deaths among tuberculosis cases in Shanghai, China: who is at risk?. BMC Infect Dis. 2009, 17 (9): 95-CrossRef
12.
go back to reference Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B: Risk factors for death during tuberculosis treatment in Orel Russia. Int J Tuberc Lung Dis. 2004, 8 (5): 598-602.PubMed Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B: Risk factors for death during tuberculosis treatment in Orel Russia. Int J Tuberc Lung Dis. 2004, 8 (5): 598-602.PubMed
13.
go back to reference Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, Peremitin GG, Strelis AK, Murray MB: Causes of death during tuberculosis treatment in Tomsk Oblast Russia. Int J Tuberc Lung Dis. 2006, 10 (8): 857-863.PubMed Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, Peremitin GG, Strelis AK, Murray MB: Causes of death during tuberculosis treatment in Tomsk Oblast Russia. Int J Tuberc Lung Dis. 2006, 10 (8): 857-863.PubMed
14.
go back to reference Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P: Tuberculosis-related deaths in Queensland, Australia, 1989–1998: characteristics and risk factors. Int J Tuberc Lung Dis. 2003, 7 (8): 742-750.PubMed Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P: Tuberculosis-related deaths in Queensland, Australia, 1989–1998: characteristics and risk factors. Int J Tuberc Lung Dis. 2003, 7 (8): 742-750.PubMed
15.
go back to reference Xie HJ, Enarson DA, Chao CW, Allen EA, Grzybowski S: Deaths in tuberculosis patients in British Columbia, 1980–1984. Tuber Lung Dis. 1992, 73 (2): 77-82. 10.1016/0962-8479(92)90059-S.CrossRefPubMed Xie HJ, Enarson DA, Chao CW, Allen EA, Grzybowski S: Deaths in tuberculosis patients in British Columbia, 1980–1984. Tuber Lung Dis. 1992, 73 (2): 77-82. 10.1016/0962-8479(92)90059-S.CrossRefPubMed
16.
go back to reference Zafran N, Heldal E, Pavlovic S, Vuckovic D, Boe J: Why do our patients die of active tuberculosis in the era of effective therapy?. Tuber Lung Dis. 1994, 75 (5): 329-333. 10.1016/0962-8479(94)90077-9.CrossRefPubMed Zafran N, Heldal E, Pavlovic S, Vuckovic D, Boe J: Why do our patients die of active tuberculosis in the era of effective therapy?. Tuber Lung Dis. 1994, 75 (5): 329-333. 10.1016/0962-8479(94)90077-9.CrossRefPubMed
17.
go back to reference Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Weiner M, Vernon A: Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis. 2006, 10 (5): 542-549.PubMed Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Weiner M, Vernon A: Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis. 2006, 10 (5): 542-549.PubMed
18.
go back to reference Heldal E, Naalsund A, Kongerud J, Tverdal A, Boe J: Deaths from active tuberculosis: can we rely on notification and mortality figures?. Tuber Lung Dis. 1996, 77 (3): 215-219. 10.1016/S0962-8479(96)90003-9.CrossRefPubMed Heldal E, Naalsund A, Kongerud J, Tverdal A, Boe J: Deaths from active tuberculosis: can we rely on notification and mortality figures?. Tuber Lung Dis. 1996, 77 (3): 215-219. 10.1016/S0962-8479(96)90003-9.CrossRefPubMed
19.
go back to reference Hooi LN, Goh KY: A hospital based audit of tuberculosis deaths. Med J Malaysia. 1995, 50 (4): 306-313.PubMed Hooi LN, Goh KY: A hospital based audit of tuberculosis deaths. Med J Malaysia. 1995, 50 (4): 306-313.PubMed
20.
go back to reference Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, Glaziou P, Gopi PG, Hosseini M, Kim SJ, Manissero D, et al: Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis. 2008, 8 (4): 233-243. 10.1016/S1473-3099(07)70291-8.CrossRefPubMed Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, Glaziou P, Gopi PG, Hosseini M, Kim SJ, Manissero D, et al: Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis. 2008, 8 (4): 233-243. 10.1016/S1473-3099(07)70291-8.CrossRefPubMed
21.
go back to reference Kircher T, Nelson J, Burdo H: The autopsy as a measure of accuracy of the death certificate. N Engl J Med. 1985, 313 (20): 1263-1269. 10.1056/NEJM198511143132005.CrossRefPubMed Kircher T, Nelson J, Burdo H: The autopsy as a measure of accuracy of the death certificate. N Engl J Med. 1985, 313 (20): 1263-1269. 10.1056/NEJM198511143132005.CrossRefPubMed
23.
go back to reference Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994, 149 (3 Pt 1): 818-824.CrossRefPubMed Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994, 149 (3 Pt 1): 818-824.CrossRefPubMed
24.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.CrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.CrossRefPubMed
25.
go back to reference Moniruzzaman A, Elwood RK, Wong H, Kazanjian A, FitzGerald JM: A seventeen-year study of TB diagnosed postmortem in British Columbia, Canada. Am J Respir Crit Care Med. 2009, 179: A5279- Moniruzzaman A, Elwood RK, Wong H, Kazanjian A, FitzGerald JM: A seventeen-year study of TB diagnosed postmortem in British Columbia, Canada. Am J Respir Crit Care Med. 2009, 179: A5279-
26.
go back to reference Dyer RA, Chappell WA, Potgieter PD: Adult respiratory distress syndrome associated with miliary tuberculosis. Crit Care Med. 1985, 13 (1): 12-15. 10.1097/00003246-198501000-00004.CrossRefPubMed Dyer RA, Chappell WA, Potgieter PD: Adult respiratory distress syndrome associated with miliary tuberculosis. Crit Care Med. 1985, 13 (1): 12-15. 10.1097/00003246-198501000-00004.CrossRefPubMed
27.
go back to reference Lintin SN, Isaac PA: Miliary tuberculosis presenting as adult respiratory distress syndrome. Intensive Care Med. 1988, 14 (6): 672-674.CrossRefPubMed Lintin SN, Isaac PA: Miliary tuberculosis presenting as adult respiratory distress syndrome. Intensive Care Med. 1988, 14 (6): 672-674.CrossRefPubMed
28.
go back to reference Kim YJ, Pack KM, Jeong E, Na JO, Oh YM, Lee SD, Kim WS, Kim DS, Kim WD, Shim TS: Pulmonary tuberculosis with acute respiratory failure. Eur Respir J. 2008, 32 (6): 1625-1630. 10.1183/09031936.00070907.CrossRefPubMed Kim YJ, Pack KM, Jeong E, Na JO, Oh YM, Lee SD, Kim WS, Kim DS, Kim WD, Shim TS: Pulmonary tuberculosis with acute respiratory failure. Eur Respir J. 2008, 32 (6): 1625-1630. 10.1183/09031936.00070907.CrossRefPubMed
29.
go back to reference Pagel W: The evolution of tuberculosis in man. Pulmonary Tuberculosis. Edited by: Pagel W, Simmonds FAH, Norman M. 1964, London: Oxford Medical Publisher, pp 147-pp 161. 4 Pagel W: The evolution of tuberculosis in man. Pulmonary Tuberculosis. Edited by: Pagel W, Simmonds FAH, Norman M. 1964, London: Oxford Medical Publisher, pp 147-pp 161. 4
30.
go back to reference Angoulvant D, Mohammedi I, Duperret S, Bouletreau P: Septic shock caused by Mycobacterium tuberculosis in an non-HIV patient. Intensive Care Med. 1999, 25 (2): 238-10.1007/s001340050825.CrossRefPubMed Angoulvant D, Mohammedi I, Duperret S, Bouletreau P: Septic shock caused by Mycobacterium tuberculosis in an non-HIV patient. Intensive Care Med. 1999, 25 (2): 238-10.1007/s001340050825.CrossRefPubMed
31.
go back to reference Pene F, Papo T, Burdy-Gulphe L, Cariou A, Piette JC, Vinsonneau C: Septic shock and thrombotic microangiopathy due to Mycobacterium tuberculosis in a nonimmunocompromised patient. Arch Intern Med. 2001, 161 (10): 1347-1348. 10.1001/archinte.161.10.1347.CrossRefPubMed Pene F, Papo T, Burdy-Gulphe L, Cariou A, Piette JC, Vinsonneau C: Septic shock and thrombotic microangiopathy due to Mycobacterium tuberculosis in a nonimmunocompromised patient. Arch Intern Med. 2001, 161 (10): 1347-1348. 10.1001/archinte.161.10.1347.CrossRefPubMed
32.
go back to reference Michel P, Barbier C, Loubiere Y, Hayon JH, Ricôme JL: Three cases of septic shock due to tuberculosis without HIV pathology. Intensive Care Med. 2002, 28 (12): 1827-1828. 10.1007/s00134-002-1526-9.CrossRefPubMed Michel P, Barbier C, Loubiere Y, Hayon JH, Ricôme JL: Three cases of septic shock due to tuberculosis without HIV pathology. Intensive Care Med. 2002, 28 (12): 1827-1828. 10.1007/s00134-002-1526-9.CrossRefPubMed
33.
go back to reference Achkar JM, Lawn SD, Moosa MY, Wright CA, Kasprowicz VO: Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration. J Infect Dis. 2011, 15 (Suppl 4): S1130-S1141.CrossRef Achkar JM, Lawn SD, Moosa MY, Wright CA, Kasprowicz VO: Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration. J Infect Dis. 2011, 15 (Suppl 4): S1130-S1141.CrossRef
Metadata
Title
Tuberculosis mortality: patient characteristics and causes
Authors
Chou-Han Lin
Chou-Jui Lin
Yao-Wen Kuo
Jann-Yuan Wang
Chia-Lin Hsu
Jong-Min Chen
Wern-Cherng Cheng
Li-Na Lee
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-5

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.